In the winter of 2017, a group of regulatory, operations, clinical, I.T. and other backgrounds from 50 healthcare industry stakeholder companies and associations came together as a team to explore the use of blockchain technology to support Drug Supply Chain Security Act (DSCSA) compliance and to add additional value.

This 54-page white paper provides insights into the process, exploration and learnings throughout the study. Future teams will build upon the learnings of this group and take the next steps of building proof of technology, proof of concept, pilots and extensions on the basic DSCSA data set used in this work. Download for details about:

• The Drug Supply Chain Security Act and blockchain
  

• Study concepts, scenarios and challenges
  

• Reference models and evaluations
  

• Other findings and thoughts
• Next steps